and Sanofi/Regeneron's Praluent (alirocumab), which have list prices of $14,000 each. Express Scripts now expects to spend no more than $750 million on the drugs in 2016, far lower than industry ...

The drug companies and the insurance companies want us fat and unhealthy. One of the worst experiences I’ve ever had—Express Scripts is a quintessentially nefarious insurance corporation.

(AP) — Kentucky's attorney general has sued Express ... drugs. Kentucky has been at the epicenter of the crisis with some of ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The FTC’s lawsuit comes just days after Express Scripts ... list price of Lilly’s insulin Humalog jumped more than 1,200% ...

Dr Steve Miller, chief medical officer at Express Scripts, says it makes no sense for cancer drugs to have the same price no matter what cancer they are treating, as the data shows some tumour ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

In the case of one drug, nortriptyline, Express Scripts had been paying Yough Valley ... grew up in one of the communities on his list: Harmony, Minn., where his parents once owned the only ...

In a sample of 100 hospitals, 34 didn’t meet requirements for publishing machine-readable files of their charges while 14 ...

Independent pharmacies have filed 3 class action lawsuits against GoodRx Holdings and major pharmacy benefit managers (PBMs).